ID: MRFR/HC/5908-HCR | August 2022 | Region: Global | 110 Pages
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Overview
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
Chapter 5. Market Factor Analysis
5.1 Porterβs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
Chapter 6. Global Fetal Bovine Serum Market, by Product type
6.1 Overview
6.2 Charcoal Stripped
6.3 Chromatographic
6.4 Dialyzed Fetal Bovine Serum (FBS)
6.5 Exosome Depleted
6.6 Stem Cell
6.6.1 Embryonic Stem Cells Qualified
6.6.2 Mesenchymal Stem Cell Qualified
6.7 Others
Chapter 7. Global Fetal Bovine Serum Market, by Application
7.1 Overview
7.2 Drug Discovery
7.3 Cell Culture Media
7.4 In Vitro Fertilization
7.5 Human & Animal Vaccine Production
7.6 Diagnostics
7.7 Others
Chapter 8. Global Fetal Bovine Serum Market, by End User
8.1 Introduction
8.2 Research & Academic Institutes
8.3 Pharmaceutical
8.4 Biotech
8.5 Others
Chapter 9. Global Fetal Bovine Serum Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 Latin America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
Chapter 11. Company Profiles
11.1 HiMedia Laboratories
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Merck KGaA
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Bovogen Biologicals Pty Ltd
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Atlanta Biologicals Inc.
11.4.1 Company Overview
11.4.2 Product Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 TCS Biosciences Ltd
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Tissue Culture Biologicals
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Rocky Mountain Biologicals
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 GE Healthcare
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Thermo Fisher Scientific
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Bio-Techne
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 PAN-Biotech
11.11.1 Overview
11.11.2 Product Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Others
Chapter 12. Appendix
β
LIST OF TABLES
Table 1 Global Fetal bovine serum Market Synopsis, 2020-2027
Table 2 Global Fetal bovine serum Market Estimates and Forecast, 2020-2027 (USD Million)
Table 3 Global Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 4 Global Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 5 Global Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 6 Global Fetal bovine serum Market, by Region, 2020-2027(USD Million)
Table 7 North America: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 8 North America: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 9 North America: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 10 North America: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
Table 11 US: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 12 US: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 13 US: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 14 US: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
Table 15 Canada: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 16 Canada: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 17 Canada: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 18 Canada: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
Table 19 South America: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 20 South America: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 21 South America: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 22 South America: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
Table 23 Europe: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 24 Europe: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 25 Europe: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 26 Europe: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
Table 27 Western Europe: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 28 Western Europe: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 29 Western Europe: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 30 Western Europe: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
Table 31 Eastern Europe: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 32 Eastern Europe: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 33 Eastern Europe: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 34 Eastern Europe: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
Table 35 Asia-Pacific: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 36 Asia-Pacific: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 37 Asia-Pacific: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 38 Asia-Pacific: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
Table 39 Middle East & Africa: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 40 Middle East & Africa: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 41 Middle East & Africa: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 42 Middle East & Africa: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Fetal bovine serum Market
Figure 3 Market Dynamics for Global Fetal bovine serum Market
Figure 4 Global Fetal bovine serum Market Share, by Product type, 2020 (%)
Figure 5 Global Fetal bovine serum Market Share, by Application, 2020 (%)
Figure 6 Global Fetal bovine serum Market Share, by End User, 2020 (%)
Figure 7 Global Fetal bovine serum Market Share, by Region, 2020 (%)
Figure 8 North America: Fetal bovine serum Market Share, by Country, 2020 (%)
Figure 9 Europe: Fetal bovine serum Market Share, by Country, 2020 (%)
Figure 10 Asia-Pacific: Fetal bovine serum Market Share, by Country, 2020 (%)
Figure 11 Middle East & Africa: Fetal bovine serum Market Share, by Country, 2020 (%)
Figure 12 Global Fetal bovine serum Market: Company Share Analysis, 2020 (%)
Figure 13 HiMedia Laboratories: Key Financials
Figure 14 HiMedia Laboratories: Segmental Revenue
Figure 15 HiMedia Laboratories: Geographical Revenue
Figure 16 Merck KGaA: Key Financials
Figure 17 Merck KGaA: Segmental Revenue
Figure 18 Merck KGaA: Geographical Revenue
Figure 19 Bovogen Biologicals Pty Ltd: Key Financials
Figure 20 Bovogen Biologicals Pty Ltd: Segmental Revenue
Figure 21 Bovogen Biologicals Pty Ltd: Geographical Revenue
Figure 22 Biomerics: Key Financials
Figure 23 Biomerics: Segmental Revenue
Figure 24 Biomerics: Geographical Revenue
Figure 25 TCS Biosciences Ltd: Key Financials
Figure 26 TCS Biosciences Ltd: Segmental Revenue
Figure 27 TCS Biosciences Ltd: Geographical Revenue
Figure 28 Tissue Culture Biologicals: Key Financials
Figure 29 Tissue Culture Biologicals: Segmental Revenue
Figure 30 Tissue Culture Biologicals: Geographical Revenue
Figure 31 Rocky Mountain Biologicals: Key Financials
Figure 32 Rocky Mountain Biologicals: Segmental Revenue
Figure 33 Rocky Mountain Biologicals: Geographical Revenue
Figure 34 GE Healthcare: Key Financials
Figure 35 GE Healthcare: Segmental Revenue
Figure 36 GE Healthcare: Geographical Revenue
Figure 37 Thermo Fisher Scientific: Key Financials
Figure 38 Thermo Fisher Scientific: Segmental Revenue
Figure 39 Thermo Fisher Scientific: Geographical Revenue
Figure 40 Bio-Techne: Key Financials
Figure 41 Bio-Techne: Segmental Revenue
Figure 42 Bio-Techne: Geographical Revenue
Figure 43 PAN-Biotech: Key Financials
Figure 44 PAN-Biotech: Segmental Revenue
Figure 45 PAN-Biotech: Geographical Revenue
$1,375.55 million
5.6%
North America
2022-2030
The fetal bovine serum market share is expected to do good in the ongoing forecast period of 2020-2030. The market is likely to attain a global CAGR of 8.5% during the period and hence, reach a good market sum by the end of the period, as predicted by the business chiefs and industry experts.
Fetal bovine serum can be recognized as a type of by-product which is produced in the meat processing companies industries. The processes involve the use of several well-known applications that are employed especially in the pharmaceutical and biotechnology research industries. Fetal bovine serum is known to be attained from the whole blood of normal bovine fetuses. It is broadly used in an array of applications that are inclusive of some diagnostic systems and research studies.
COVID 19 Analysis of Fetal Bovine Serum Market
The fetal bovine serum market was gearing up for growth and was working on the strategies that will help the market dissolve the studied challenges for the market that will be ending in 2028. However, the sudden outbreak of the coronavirus pandemic has changed the total game for the market trends. The rising healthcare emergency is pushing people to alter their lifestyle and living methods so that they do not contract the infection which will deteriorate their condition. The rising fatalities and dangers that have been introduced because of the spread of the pandemic have resulted in the collapse of the global and established healthcare systems. The rising cases of the pandemic have led to the changing market trends and also, the global governments have been pushed to take important steps for the safety and healthcare of people.
However, the fetal bovine serum market is also witnessing a major need for the market to return to normalcy to maintain the market equilibrium between the demand and supply of the global market products and services. Also, the market is witnessing a reduced availability of investment and funds. The government and public sector along with the prominent players of the growing fetal bovine serum market size are collaborating to meet the investment needs that will help in fueling the growth of the market and cover the losses that have been incurred during the pandemic year of 2020.
Market Dynamics
Drivers
The fetal bovine serum market trends are witnessing a rapid increase in the degree of culture media consumption especially in the developing countries across the worldwide location which is emerging as one of the important factors intensifying the growth and thus, fetch a huge demand of fetal bovine serum market in the global market premises. In addition, the growing degree of demand from traditional users of serum is also known to be contributing to the growth in the global fetal bovine serum market over the forecast period of 2021 to 2028.
Restraints
However, the FBS report predicts that the market is likely to witness the growth of factors like the decrease in cattle herd population due to the increased demand for dairy and meat products. This factor holds the potential and is expected to restrain the fetal bovine serum market growth during the forecast period that is scheduled to be ending in 2028.
Technology Analysis
The fetal bovine serum (FBS) market is on the rise to be witnessing a major degree of advancements and investment in the research activities followed by the rise in the academic initiatives by the private and governmental sector that is expected to drive the global fetal bovine serum market growth during the ongoing forecast period that is expected to be ending in 2028. Further, there has been a substantial increase in demand from traditional users of the market products and services like serum which is also expected to drive the growth of the market as per the predictions that have been laid down for the market. As the fetal bovine serum is known to have a higher degree of efficiency rate in comparison to the normal blood serum which is further, expected to boost the growth of the overall serum market during the period that ends in 2028.
Study Objectives
Segment Overview
The serum market size is known to be expanding during the current forecast period because of an excellent performance that has been recorded by the following fetal bovine serum market segments:
Based on the product type
The fetal bovine serum market is categorized into Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum (FBS), Exosome Depleted, Stem Cell, and others. Further, the stem cell segment of the market is divided into embryonic stem cells qualified, and mesenchymal stem cell qualified.
Based on the market application
The fetal bovine serum market is segmented based on applications and includes drug discovery, cell culture media, in-vitro fertilization, human and animal vaccine production, diagnostics, amongst others.
Based on the market end-users
The fetal bovine serum market is segmented based on the market end-users and includes research and academic institutes, pharmaceutical, biotechnology, and others.
Regional Analysis
It is projected that the American region is likely to dominate the fetal bovine serum market. The main reason behind this is the growth of the market in the North American region. The growth is largely attributed to the rising market factors such as an increase in research funding, and growing awareness about the high-end fetal bovine serum among medical professionals.
Also, the European region is currently holding a considerable amount of market share in the fetal bovine serum market. However, the region is predicted to undergo a declined growth due to ethical issues and religious sentiments.
Competitive Landscape
The competitive players of the market are:
Recent Developments
Intended Audience
Report Overview
The serum market report is likely to cover the major market aspects that will lead the market towards growth and attain the predicted trends of the market for the forecast period that will be ending in 2028. The fetal bovine serum market report discusses the functioning of the market segments and the recent developments that have been undertaken in the industry premises.
Report Attribute/Metric | Details |
---|---|
Market Size | 2030: Significant Value |
CAGR | 2020-2030: 8.5% |
Base Year | 2019 |
Forecast Period | 2030 |
Historical Data | 2018 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Product Type, Application and End User |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | HiMedia Laboratories, Merck KGaA, Bovogen Biologicals Pty Ltd, Atlanta Biologicals Inc., TCS Biosciences Ltd, Tissue Culture Biologicals, Rocky Mountain Biologicals, GE Healthcare, Thermo Fisher Scientific, Bio-Techne, PAN-Biotech, Access Biologicals, Animal Technologies Inc., Nucleus Biologics, Biological Industries, Corning Incorporated |
Key Market Opportunities | Research funding, and growing awareness about the high-end fetal bovine serum among medical professionals. |
Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Fetal bovine serum market is projected to grow at an 8.5% CAGR between 2020-2030.
The Americas is expected to lead the fetal bovine serum market.
Product shortage may limit the fetal bovine serum market.
Major applications of the fetal bovine serum market include diagnostics, drug discovery, in-vitro fertilization, and others.